Stay updated on Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Sign up to get notified when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added and an older revision (v3.4.1) was removed. The latest version also includes the 'Study Status' section in the history view.
    Difference
    0.3%
    Check dated 2026-02-12T02:06:14.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The history shows a new revision entry for v3.4.1 and the deletion of the previous revision v3.4.0. It reflects an administrative update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-02-04T22:50:41.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The history page adds a glossary toggle and a legend for color-coded changes (green for additions, red for deletions) in the study record view, and updates the footer to Revision: v3.4.0 with minor text tweaks such as capitalization changes for 'No FEAR Act'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-01-28T17:20:26.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Minor platform version update reflected in the Record History page: Revision v3.3.4 added and Revision v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:57:33.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.3 appears on the page, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' are removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T22:19:20.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page history now lists Revision: v3.3.2, replacing v3.2.0. This appears to be a routine system release update rather than a change to study content or user-facing functionality.
    Difference
    0.1%
    Check dated 2025-11-25T11:49:06.000Z thumbnail image

Stay in the know with updates to Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.